Bio Strategy Advisors
A strategic business consulting firm servicing small and medium-sized Biotech and MedTech companies.
​
Specializing in:
​
-
Start-ups: corporate strategy, value creation planning, investment thesis, exit scenarios, strategic partnerships, M&A transactions. Preparation for early-round fund-raising, deck preparation, transaction terms advice, and outreach. Asset pipeline and clinical development program planning.
​
-
Later-stage companies: commercial planning, go-to-market models, alliance establishment, licensing and full-service distribution deals, geographical expansion, patient advocacy, market access, and product launch strategy.
Why Bio Strategy Advisors?
-
Hands-on assistance for Founders/CEO’s/CCO’s on the refinement of Corporate and Commercial Strategy.
-
Extensive experience in company formation and building of Biotech and MedTech organizations.
-
Sound advice on fundraising, structuring and negotiating deal terms, definitive agreements, and initial alliance management.
-
Proven track record on geographical expansion and determining go-to-market models for a solid global footprint, global product launches.
-
Established contact and relationships with partners for licensing or full-service distribution or 3PLs in the different regions (US, EU, Canada, Asia, LATAM).
-
Deep expertise in product launches for specialty therapeutics, orphan drugs/rare diseases, and complex devices.
